Association of the mitochondrial tRNA(A4336G) mutation with Alzheimer's and Parkinson's diseases

Neuropathology and Applied Neurobiology

Volumn 23, Issue 4, 1997, Pages 315-321

  Egensperger, R ^a   Kosel S ^a   Schnopp, N M ^a   Mehraein, P ^a   Graeber, M B ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b Institute of Neuropathology   (Germany)

Author keywords

Alpha1 antichymotrypsin; Alzheimer's disease; Apolipoprotein E; Mitochondrial DNA; Oxidative phosphorylation; Parkinson's disease; Susceptibility gene

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; APOLIPOPROTEIN E4; MITOCHONDRIAL RNA; TRANSFER RNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CADAVER; CONTROLLED STUDY; DISEASE ASSOCIATION; ETIOLOGY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; LEWY BODY; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; NORMAL HUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030811838     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2990.1997.tb01301.x     Document Type: Article

References (42)

1. Attardi G. The human mitochondrial genetic system. In Mitochondrial DNA in Human Pathology, Eds S DiMauro, DC Wallace. New York: Raven Press. 1993: 9-25
2. Blass J, Baker A, Ko L, Black R. Induction of Alzheimer antigens by an uncoupler of oxidative phosphorylation. Arch Neurol 1990; 47: 864-9
3. Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 1991; 82: 239-59
4. Corder EH, Saunders AM, Strittmatter WJ et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 1993; 261: 921-3
5. Corral-Debrinski M, Horton T, Lott MT, Shoffner JM, Beal MF, Wallace DC. Mitochondrial DNA deletions in human brain: regional variability and increase with advanced age. Nature Genet 1992; 2: 324-9
6. Ditter SM, Mirra SS. Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 1987; 37: 754-60
7. Egensperger R, Kösel S, Schnabel R, Mehraein P, Graeber MB. Apolipoprotein E genotype and neuropathological phenotype in two members of a German family with chromosome 14-linked early onset Alzheimer's disease. Acta Neuropathol 1995; 90: 257-65
8. Goate A, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-6
9. Goodfellow PN, Schmitt K. From the simple to the complex. Science 1994; 371: 105
10. Haines JL, Pritchard ML, Saunders AM et al. No genetic effect of alpha(1)-antichymotrypsin in Alzheimer disease. Genomics 1996; 33: 53-6
11. Harding AE. Growing old: the most common mitochondrial disease of all? Nat Genet 1992; 2: 251-2
12. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinicopathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55: 181-4
13. Hutchin T, Cortopassi G. A mitochondrial DNA clone is associated with increased risk for Alzheimer disease. Proc Natl Acad Sci USA 1995; 92: 6892-5
14. Kamboh MI, Sanghera DK, Ferrell RE, DeKosky ST. APOE*4-associated Alzheimer's disease risk is modified by α1-antichemotrypsin polymorphism. Natl Genet 1995; 10: 486-8
15. Kösel S, Graeber MB. Use of neuropathological tissue for molecular genetic studies: parameters affecting DNA extraction and polymerase chain reaction. Acta Neurophatol 1994; 88: 19-25
16. Kösel S, Lücking CB, Egensperger R, Mehraein P, Graeber MB. Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy-body Parkinsonism. J Neurosci Res 1996; 44: 174-83
17. Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for the chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-7
18. Maurer I, Ziez S, Moller HJ, Jerusalem F. Cytochrome c oxidase in Alzheimer's disease. Neurology 1995; 45: 1423
19. Mayeux R, Denaro J, Hamenegildo N et al. A population-based investigation of Parkinson's disease with and without dementia. Arch Neurol 1992; 49: 492-7
20. Mirra SS, Hart MN, Terry RD. Making the diagnosis of Alzheimer's disease - a primer for practicing pathologists. Arch Pathol Lab Med 1993; 117: 132-44
21. Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-86
22. Mizuno Y, Ohta S, Tanaka M et al. Deficiencies in complex 1 subunits of respiratory chain in Parkinson's disease. Biochem Biophys Res Commun 1989; 163: 1450-5
23. Müller U, Bödeker R-H, Gerundt I, Kurz A. Lack of association between α1-antichymotrypsin polymorphism. Alzheimer's disease and allele ε4 of apolipoprotein E. Neurology 1996; 47: 1575-7
24. Parker WD. Cytochrome oxidase deficiency in Alzheimer's disease. Ann N Y Acad Sci 1992; 640: 59-64
25. Parker WD, Mahr NJ, Filley CM et al. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology 1994; 44: 1086-90
26. Parker WD, Parks J, Filley CM, Kleinschmidt-DeMasters BK. Electron transport chain defects in Alzheimer's disease brain. Neurology 1994; 44: 1090-6
27. Plomin R, Owen MJ, McGuffin P. The genetic basis of complex human behaviors. Science 1994; 264: 1733-9
28. Rinne JO, Rummukainen J, Palijärvi L, Rinne UK. Dementia in Parkinson's disease is related to neuronal loss in the medial substantia nigra. Ann Neurol 1989; 26: 47-50
29. Rogaev EI, Sherrington R, Rogaeva EA et al. Familiar Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature 1995; 376: 775-8
30. Roses AD. Apolipoprotein E genotyping in the differential diagnosis, not prediction, of Alzheimer's disease. Ann Neurol 1995; 38: 6-14
31. Saunders AM, Strittmatter WJ, Schmechel D et al. Association of apolipoprotein E allele epsilon-4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993; 43: 1467-72
32. Schapira AHV, Cooper JM, Dexter D, Jenner P, Clark JB, Marsden CD. Mitochondrial complex I deliciency in Parkinson's disease. Lancet 1989; i: 1269
33. Schmechel DE, Saunders AM, Strittmatter WJ et al. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 9649-53
34. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early-onset familiar Alzheimer's disease. Nature 1995; 375: 754-60
35. Shoffner JM, Brown MD, Torroni A et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. Genomics 1993; 17: 171-84
36. Shoffner JM, Watts R, Juncos JL, Torroni A, Wallace DC. Mitochondrial oxidative phosphorylation defects in Parkinson's disease. Ann Neurol 1991; 30: 332-9
37. Simonian NA, Hyman BT. Functional alterations in Alzheimer's disease: selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation. J Neuropathol Exp Neurol 1994; 53: 508-12
38. Strittmatter WJ, Saunders AM, Schmechel D et al. Apolipoprotein E: High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993; 90: 1977-81
39. Talbot C, Houlden H, Craddock N et al. Polymorphism in AACT gene may lower age of onset of Alzheimer's disease. Neuroreport 1996; 7: 534-6
40. Wallace DC, Mitochondrial DNA sequence variation in human evolution and disease. Proc Natl Acad Sci USA 1994; 91: 8739-46
41. Wisniewski HM, Wegiel J, Kotula L. Some neuropathological aspects of Alzheimer's disease and its relevance to other disciplines. Neuropathol Appl Neurobiol 1996; 22: 3-11
42. Wragg MA, Talbot CJ, Morris JC, Lendon CL, Goate AM. No association found between Alzheimer's disease and a mitochondrial tRNA glutamine gene variant. Neurosci Lett 1995; 201: 107-10.